Pulmonology
- DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease
- MANUFACTURER: Theravance Biopharma
- USAGE: Oral
- MEDICINE APPROVED BY:
- Food and Drug Administration (FDA)
Yupelri (revefenacin) is a medication approved by the Food and Drug Administration (FDA) for the treatment of patients with COPD.It is a bronchodilator, specifically classified as a long-acting muscarinic antagonist (LAMA), and it is primarily used in the management of chronic obstructive pulmonary disease (COPD). This medication is designed to help individuals with COPD breathe more easily by relaxing and opening up the airways in their lungs.
Read more
